Nonetheless, the previous study revealed that chronic intermittent hypoxia for OSA reduced type 2 airway inflammation with decreased interleukin-5 and interleukin-13 in an animal model [55]. The gene discussed is IL13; the disease is obstructive sleep apnea syndrome.